Literature DB >> 27547951

Use of High-cost Systemic Treatments in Elderly mCRC Patients.

Cathy J Bradley1, K Robin Yabroff, Joan L Warren, Christopher Zeruto, Neetu Chawla, Elizabeth B Lamont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27547951      PMCID： PMC5145731          DOI： 10.1097/MLR.0000000000000612

Source DB:  PubMed          Journal:  Med Care        ISSN： 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  6 in total

1.  Comparison of performance of traditional Medicare vs Medicare managed care.

Authors:  Bruce E Landon; Alan M Zaslavsky; Shulamit L Bernard; Matthew J Cioffi; Paul D Cleary
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

2.  Access, affordability, and insurance complexity are often worse in the United States compared to ten other countries.

Authors:  Cathy Schoen; Robin Osborn; David Squires; Michelle M Doty
Journal:  Health Aff (Millwood)       Date:  2013-11-13       Impact factor: 6.301

3.  Quality assessments by sick and healthy beneficiaries in traditional Medicare and Medicare managed care.

Authors:  Patricia S Keenan; Marc N Elliott; Paul D Cleary; Alan M Zaslavsky; Bruce E Landon
Journal:  Med Care       Date:  2009-08       Impact factor: 2.983

4.  Trends in the Treatment of Metastatic Colon and Rectal Cancer in Elderly Patients.

Authors:  Cathy J Bradley; K Robin Yabroff; Joan L Warren; Christopher Zeruto; Neetu Chawla; Elizabeth B Lamont
Journal:  Med Care       Date:  2016-05       Impact factor: 2.983

5.  How do the experiences of Medicare beneficiary subgroups differ between managed care and original Medicare?

Authors:  Marc N Elliott; Amelia M Haviland; Nate Orr; Katrin Hambarsoomian; Paul D Cleary
Journal:  Health Serv Res       Date:  2011-02-09       Impact factor: 3.402

6.  A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.

Authors:  Rajiv Kumar; Kunal Jain; Carol Beeke; Timothy J Price; Amanda R Townsend; Rob Padbury; David Roder; Graeme P Young; Alison Richards; Christos S Karapetis
Journal:  Cancer       Date:  2012-09-18       Impact factor: 6.860
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.